Overcoming Challenges in Infectious Diseases
Discover the latest medical research on the prevention, management and treatment of infectious diseases.
LATEST TOPICS
-
Sitafloxacin Demonstrates Excellent Activity Against Ciprofloxacin-Resistant Neisseria gonorrhoeae Isolates9 May, 2018Neisseria gonorrhoeae is a sexually-transmitted pathogen that may cause asymptomatic infection or may clinically present as urethritis, cervicitis, pharyngitis or proctitis.1 In women, untreated...
-
Sitafloxacin demonstrates excellent in vitro activity against a global panel of antimicrobial-resistant and multidrug-resistant Neisseria gonorrhoeae9 May, 2018The World Health Organization (WHO) estimated in 2012 that 78 million new cases of urogenital gonorrhoea occur among adults annually.1 The emergence of N. gonorrhoeae resistant to ceftriaxone, the...
-
Levofloxacin-loaded chitosan nanoparticle formulation improves ocular delivery and antimicrobial activity against Pseudomonas aeruginosa and Staphylococcus aureus9 May, 2018Ophthalmologic infections can be challenging to treat because of the relative impermeability of the cornea. It is estimated that only 1% to 5% of the applied topical antibiotic penetrates into the...
-
Second Case of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Reported in Malaysia9 May, 2018The National IHR Focal Point of Malaysia reported a case of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) on 2 January 2018.1 The patient was a 55-year-old male residing in Malaysia who...
-
The Way Forward: High-Dose, Short-Course Levofloxacin Leads the Field29 March, 2018A new generation of fluoroquinolone treatment has begun with the advent of the high-dose, short-course levofloxacin regimen. It may seem to many working in the field of infectious diseases that... -
Tracking Susceptibility and Reducing Resistance - Fluoroquinolones at the Forefront in the Fight Against Bacterial Pathogens29 March, 2018Although the focus of infectious disease in 2009 has been the Influenzae A (H1N1) virus, physicians and patients must not forget bacterial pathogens continue as a major threat. Many bacterial... -
Optimal Antimicrobial Therapy for Prostatitis29 March, 2018Optimal management of acute bacterial prostatitis begins with empiric parenteral fluoroquinolones or β-lactams before switching to oral administration, with adjustments made according to... -
The Treatment of Community-Acquired Pneumonia with Consideration of Mycobacterium Tuberculosis29 March, 2018A meeting of leading Asian experts in respiratory tract infections (RTIs) and tuberculosis (TB) was held on 27th July 2012, in Tokyo, Japan. This meeting brought together clinicians and... -
Optimal Management of RTI – Intriguing New Results in ABECOPD in Asia29 March, 2018Respiratory tract infections (RTI) continue to pose serious problems for patients and health care systems around the world. It is fortunate that the respiratory fluoroquinolones, lead by... -
Research and Development of Quinolones in Daiichi Sankyo Co., Ltd.28 March, 2018Shogo Atarashi, PhD Senior Advisor, Marketing Department, ASCA Company, Daiichi Sankyo Co., Ltd., Tokyo, Japan Quinolones, which are antimicrobials first launched in the 1960s, have exhibited...
CONTENT LIBRARY
CONTENT LIBRARY
INTERVIEWS
-
The Way Forward: High-Dose, Short-Course Levofloxacin Leads the Field
-
Tracking Susceptibility and Reducing Resistance – Fluoroquinolones at the Forefront in the Fight Against Bacterial Pathogens
-
Optimal Antimicrobial Therapy for Prostatitis
-
Optimal Management of RTI – Intriguing New Results in ABECOPD in Asia
-
Levofloxacin — An Extremely Useful Drug in the Treatment of Sinusitis -
Levofloxacin: Therapeutic Advances in the Treatment of Severe Infections -
The Role of 750 mg Once-Daily Levofloxacin in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Diseases -
The Role of Levofloxacin in Treating Urinary Tract Infections -
Levofloxacin — The “Respiratory Fluoroquinolone” -
Levofloxacin in the Treatment of Community-Acquired Pneumonia
UPCOMING EVENTS
18 May - 23 May, 2018
San Diego, CA, USA, Asia Pacific, North America
27 May - 01 June, 2018
Malmo, Sweden, Western Europe
28 May - 02 June, 2018
Malmo, Sweden, Western Europe
